About
Osteoarthritis Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (16)
Ali Guermazi
SAB Member
4Moving Biotech
team_member
Changqing Zhang
SAB Member
4Moving Biotech
team_member
Coralie Meurot
Scientific Lead
4Moving Biotech
team_member
Céline Martin
Head of R&D Operations
4Moving Biotech
team_member
Felix Eckstein
SAB Member
4Moving Biotech
team_member
Francis Berenbaum
Chairman of the SAB
4Moving Biotech
board_chairexecutivefounder
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
34
By Phase
PHASE1: 1PHASE2: 1
By Status
COMPLETED: 1WITHDRAWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05419856Lead Sponsor
Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
PHASE1Completed
34 participants
Started: Aug 9, 2022 · Completed: Oct 31, 2023
NCT05411575Lead Sponsor
Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)
PHASE2Withdrawn
Started: Jul 19, 2022 · Completed: Oct 31, 2022
Locations (1)
Headquarters
Lille, France
Map
Loading map...